معرفی
Dr. Daniel Glaser is an Assistant Professor in the Department of Pediatrics at Yale School of Medicine, specializing in pediatric rheumatology with a focus on autoimmune and autoinflammatory conditions, particularly craniofacial scleroderma (Parry-Romberg Syndrome). He joined Yale in 2021 and previously co-founded the Pediatric Craniofacial Scleroderma Center at UPMC Children's Hospital of Pittsburgh. His research emphasizes improving diagnosis and treatment of craniofacial scleroderma through non-invasive 3D imaging and understanding its genetic basis. Clinically, he cares for children and young adults with autoimmune disorders. Dr. Glaser holds an MPH from the University of Miami and completed his residency at Yale New Haven Children's Hospital.
Education and Training:
- BA, Reed College (2009)
- MD and MPH, University of Miami (2015)
- Residency: Yale New Haven Children's Hospital (2018)
- Fellowship: UPMC Children's Hospital of Pittsburgh (2021)
Research Interests: Dr. Glaser's work centers on advancing diagnostic and monitoring tools for craniofacial scleroderma, leveraging 3D imaging to track disease progression. His research also explores the genetic underpinnings of the condition and clinical management strategies. He collaborates across disciplines to develop multidisciplinary approaches for rare pediatric rheumatic diseases.
Professional Contributions: Dr. Glaser has contributed to peer-reviewed journals and textbook chapters on pediatric rheumatology. He advocates for improving healthcare access for patients with scleroderma and supports innovative leadership programs for medical trainees.
Awards and Recognition: While specific awards for Dr. Glaser are not detailed, his contributions to pediatric rheumatology have been highlighted in departmental announcements, including the 2023-24 Department of Pediatrics Faculty Awards.
